nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS1—type 2 diabetes mellitus	0.141	0.389	CbGaD
Doxorubicin—NOS3—type 2 diabetes mellitus	0.0765	0.211	CbGaD
Doxorubicin—NDUFS3—Metformin—type 2 diabetes mellitus	0.0759	0.214	CbGbCtD
Doxorubicin—NDUFS7—Metformin—type 2 diabetes mellitus	0.0759	0.214	CbGbCtD
Doxorubicin—NDUFS2—Metformin—type 2 diabetes mellitus	0.0759	0.214	CbGbCtD
Doxorubicin—NOS2—type 2 diabetes mellitus	0.0739	0.204	CbGaD
Doxorubicin—ABCC2—type 2 diabetes mellitus	0.049	0.135	CbGaD
Doxorubicin—CYP3A4—type 2 diabetes mellitus	0.0216	0.0599	CbGaD
Doxorubicin—ABCC3—Glyburide—type 2 diabetes mellitus	0.0166	0.0468	CbGbCtD
Doxorubicin—ABCB11—Glyburide—type 2 diabetes mellitus	0.0143	0.0405	CbGbCtD
Doxorubicin—ABCC1—Glyburide—type 2 diabetes mellitus	0.0102	0.0287	CbGbCtD
Doxorubicin—ABCC2—Glyburide—type 2 diabetes mellitus	0.00754	0.0213	CbGbCtD
Doxorubicin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00746	0.021	CbGbCtD
Doxorubicin—ABCG2—Glyburide—type 2 diabetes mellitus	0.00682	0.0192	CbGbCtD
Doxorubicin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00665	0.0187	CbGbCtD
Doxorubicin—NOS3—femoral artery—type 2 diabetes mellitus	0.00501	0.0789	CbGeAlD
Doxorubicin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0048	0.0135	CbGbCtD
Doxorubicin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00453	0.0128	CbGbCtD
Doxorubicin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00447	0.0126	CbGbCtD
Doxorubicin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00418	0.0118	CbGbCtD
Doxorubicin—NOS1—arteriole—type 2 diabetes mellitus	0.004	0.0629	CbGeAlD
Doxorubicin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00398	0.0112	CbGbCtD
Doxorubicin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00364	0.0103	CbGbCtD
Doxorubicin—NOS3—middle cerebral artery—type 2 diabetes mellitus	0.00345	0.0542	CbGeAlD
Doxorubicin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00343	0.00967	CbGbCtD
Doxorubicin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0033	0.00931	CbGbCtD
Doxorubicin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00329	0.00927	CbGbCtD
Doxorubicin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00318	0.00897	CbGbCtD
Doxorubicin—NOS3—arteriole—type 2 diabetes mellitus	0.00304	0.0478	CbGeAlD
Doxorubicin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00288	0.00812	CbGbCtD
Doxorubicin—ABCB1—Glyburide—type 2 diabetes mellitus	0.00246	0.00693	CbGbCtD
Doxorubicin—ABCB1—Losartan—type 2 diabetes mellitus	0.00225	0.00634	CbGbCtD
Doxorubicin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00218	0.00615	CbGbCtD
Doxorubicin—NOS3—tunica intima—type 2 diabetes mellitus	0.00216	0.0339	CbGeAlD
Doxorubicin—NOS1—penis—type 2 diabetes mellitus	0.0021	0.033	CbGeAlD
Doxorubicin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00209	0.0059	CbGbCtD
Doxorubicin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00209	0.0059	CbGbCtD
Doxorubicin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00198	0.00558	CbGbCtD
Doxorubicin—NOS3—penis—type 2 diabetes mellitus	0.00159	0.0251	CbGeAlD
Doxorubicin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00147	0.00415	CbGbCtD
Doxorubicin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00135	0.0038	CbGbCtD
Doxorubicin—NOS3—hindlimb—type 2 diabetes mellitus	0.0012	0.0189	CbGeAlD
Doxorubicin—NOS1—artery—type 2 diabetes mellitus	0.00097	0.0153	CbGeAlD
Doxorubicin—NOS1—nerve—type 2 diabetes mellitus	0.000963	0.0151	CbGeAlD
Doxorubicin—NOS1—endothelium—type 2 diabetes mellitus	0.00082	0.0129	CbGeAlD
Doxorubicin—SLC22A16—kidney—type 2 diabetes mellitus	0.000753	0.0119	CbGeAlD
Doxorubicin—NOS3—artery—type 2 diabetes mellitus	0.000738	0.0116	CbGeAlD
Doxorubicin—NOS3—endothelium—type 2 diabetes mellitus	0.000623	0.0098	CbGeAlD
Doxorubicin—AKR1A1—islet of Langerhans—type 2 diabetes mellitus	0.000615	0.00968	CbGeAlD
Doxorubicin—ABCB8—kidney—type 2 diabetes mellitus	0.000586	0.00922	CbGeAlD
Doxorubicin—NDUFS7—islet of Langerhans—type 2 diabetes mellitus	0.000559	0.0088	CbGeAlD
Doxorubicin—ABCB8—adipose tissue—type 2 diabetes mellitus	0.000528	0.00831	CbGeAlD
Doxorubicin—AKR1A1—retina—type 2 diabetes mellitus	0.000526	0.00828	CbGeAlD
Doxorubicin—CBR3—adipose tissue—type 2 diabetes mellitus	0.000508	0.008	CbGeAlD
Doxorubicin—AKR1A1—nephron tubule—type 2 diabetes mellitus	0.000495	0.00779	CbGeAlD
Doxorubicin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.000464	0.42	CbGdCrCtD
Doxorubicin—NDUFS2—islet of Langerhans—type 2 diabetes mellitus	0.000463	0.00729	CbGeAlD
Doxorubicin—AURKA—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000463	0.419	CbGdCrCtD
Doxorubicin—NDUFS3—islet of Langerhans—type 2 diabetes mellitus	0.000458	0.0072	CbGeAlD
Doxorubicin—NDUFS7—nephron tubule—type 2 diabetes mellitus	0.00045	0.00708	CbGeAlD
Doxorubicin—AKR1A1—cardiovascular system—type 2 diabetes mellitus	0.000445	0.007	CbGeAlD
Doxorubicin—AKR1A1—kidney—type 2 diabetes mellitus	0.000435	0.00685	CbGeAlD
Doxorubicin—DHCR7—islet of Langerhans—type 2 diabetes mellitus	0.000435	0.00684	CbGeAlD
Doxorubicin—AKR1A1—pancreas—type 2 diabetes mellitus	0.000432	0.0068	CbGeAlD
Doxorubicin—AKR1A1—cortex of kidney—type 2 diabetes mellitus	0.000424	0.00667	CbGeAlD
Doxorubicin—NDUFS7—cardiovascular system—type 2 diabetes mellitus	0.000404	0.00636	CbGeAlD
Doxorubicin—YWHAG—islet of Langerhans—type 2 diabetes mellitus	0.000399	0.00628	CbGeAlD
Doxorubicin—NOS1—retina—type 2 diabetes mellitus	0.000399	0.00627	CbGeAlD
Doxorubicin—NDUFS2—retina—type 2 diabetes mellitus	0.000396	0.00623	CbGeAlD
Doxorubicin—NDUFS7—kidney—type 2 diabetes mellitus	0.000396	0.00623	CbGeAlD
Doxorubicin—AKR1A1—adipose tissue—type 2 diabetes mellitus	0.000392	0.00617	CbGeAlD
Doxorubicin—NDUFS7—cortex of kidney—type 2 diabetes mellitus	0.000385	0.00606	CbGeAlD
Doxorubicin—NDUFS2—nephron tubule—type 2 diabetes mellitus	0.000373	0.00587	CbGeAlD
Doxorubicin—DHCR7—retina—type 2 diabetes mellitus	0.000372	0.00585	CbGeAlD
Doxorubicin—ABCB8—liver—type 2 diabetes mellitus	0.00037	0.00583	CbGeAlD
Doxorubicin—Daunorubicin—ABCC2—type 2 diabetes mellitus	0.000369	0.474	CrCbGaD
Doxorubicin—NDUFS3—nephron tubule—type 2 diabetes mellitus	0.000369	0.0058	CbGeAlD
Doxorubicin—AURKA—kidney—type 2 diabetes mellitus	0.000368	0.00579	CbGeAlD
Doxorubicin—ABCC6—retina—type 2 diabetes mellitus	0.000362	0.0057	CbGeAlD
Doxorubicin—RALBP1—islet of Langerhans—type 2 diabetes mellitus	0.00036	0.00567	CbGeAlD
Doxorubicin—NDUFS7—adipose tissue—type 2 diabetes mellitus	0.000357	0.00561	CbGeAlD
Doxorubicin—DHCR7—nephron tubule—type 2 diabetes mellitus	0.00035	0.00551	CbGeAlD
Doxorubicin—YWHAG—retina—type 2 diabetes mellitus	0.000341	0.00537	CbGeAlD
Doxorubicin—NOS1—cardiovascular system—type 2 diabetes mellitus	0.000337	0.00531	CbGeAlD
Doxorubicin—CBR1—islet of Langerhans—type 2 diabetes mellitus	0.000336	0.00529	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—type 2 diabetes mellitus	0.000335	0.00527	CbGeAlD
Doxorubicin—AKR1C3—islet of Langerhans—type 2 diabetes mellitus	0.000332	0.00523	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—type 2 diabetes mellitus	0.000331	0.00521	CbGeAlD
Doxorubicin—NOS1—kidney—type 2 diabetes mellitus	0.00033	0.00519	CbGeAlD
Doxorubicin—NDUFS2—kidney—type 2 diabetes mellitus	0.000328	0.00516	CbGeAlD
Doxorubicin—NDUFS2—pancreas—type 2 diabetes mellitus	0.000326	0.00512	CbGeAlD
Doxorubicin—NDUFS3—kidney—type 2 diabetes mellitus	0.000324	0.0051	CbGeAlD
Doxorubicin—NDUFS3—pancreas—type 2 diabetes mellitus	0.000322	0.00506	CbGeAlD
Doxorubicin—NOS1—cortex of kidney—type 2 diabetes mellitus	0.000321	0.00506	CbGeAlD
Doxorubicin—NDUFS2—cortex of kidney—type 2 diabetes mellitus	0.000319	0.00502	CbGeAlD
Doxorubicin—NDUFS3—cortex of kidney—type 2 diabetes mellitus	0.000315	0.00496	CbGeAlD
Doxorubicin—RALBP1—retina—type 2 diabetes mellitus	0.000308	0.00485	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—type 2 diabetes mellitus	0.000306	0.00482	CbGeAlD
Doxorubicin—DHCR7—pancreas—type 2 diabetes mellitus	0.000306	0.00481	CbGeAlD
Doxorubicin—POR—islet of Langerhans—type 2 diabetes mellitus	0.000303	0.00477	CbGeAlD
Doxorubicin—ABCC6—kidney—type 2 diabetes mellitus	0.0003	0.00472	CbGeAlD
Doxorubicin—DHCR7—cortex of kidney—type 2 diabetes mellitus	0.0003	0.00472	CbGeAlD
Doxorubicin—NDUFS2—adipose tissue—type 2 diabetes mellitus	0.000295	0.00465	CbGeAlD
Doxorubicin—NDUFS3—adipose tissue—type 2 diabetes mellitus	0.000292	0.00459	CbGeAlD
Doxorubicin—RALBP1—nephron tubule—type 2 diabetes mellitus	0.00029	0.00456	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—type 2 diabetes mellitus	0.000289	0.00454	CbGeAlD
Doxorubicin—YWHAG—kidney—type 2 diabetes mellitus	0.000282	0.00444	CbGeAlD
Doxorubicin—YWHAG—pancreas—type 2 diabetes mellitus	0.00028	0.00441	CbGeAlD
Doxorubicin—DHCR7—adipose tissue—type 2 diabetes mellitus	0.000277	0.00436	CbGeAlD
Doxorubicin—XDH—kidney—type 2 diabetes mellitus	0.000275	0.00433	CbGeAlD
Doxorubicin—AKR1A1—liver—type 2 diabetes mellitus	0.000275	0.00433	CbGeAlD
Doxorubicin—YWHAG—cortex of kidney—type 2 diabetes mellitus	0.000275	0.00433	CbGeAlD
Doxorubicin—CBR1—nephron tubule—type 2 diabetes mellitus	0.000271	0.00426	CbGeAlD
Doxorubicin—ABCC6—adipose tissue—type 2 diabetes mellitus	0.00027	0.00425	CbGeAlD
Doxorubicin—NQO1—islet of Langerhans—type 2 diabetes mellitus	0.00027	0.00424	CbGeAlD
Doxorubicin—AKR1C3—nephron tubule—type 2 diabetes mellitus	0.000268	0.00421	CbGeAlD
Doxorubicin—RALBP1—cardiovascular system—type 2 diabetes mellitus	0.000261	0.0041	CbGeAlD
Doxorubicin—NOS3—cardiovascular system—type 2 diabetes mellitus	0.000256	0.00403	CbGeAlD
Doxorubicin—RALBP1—kidney—type 2 diabetes mellitus	0.000255	0.00401	CbGeAlD
Doxorubicin—YWHAG—adipose tissue—type 2 diabetes mellitus	0.000254	0.004	CbGeAlD
Doxorubicin—RALBP1—pancreas—type 2 diabetes mellitus	0.000253	0.00399	CbGeAlD
Doxorubicin—NOS3—kidney—type 2 diabetes mellitus	0.000251	0.00395	CbGeAlD
Doxorubicin—NDUFS7—liver—type 2 diabetes mellitus	0.00025	0.00393	CbGeAlD
Doxorubicin—RALBP1—cortex of kidney—type 2 diabetes mellitus	0.000248	0.00391	CbGeAlD
Doxorubicin—Daunorubicin—CYP1A2—type 2 diabetes mellitus	0.000247	0.316	CrCbGaD
Doxorubicin—POR—nephron tubule—type 2 diabetes mellitus	0.000244	0.00384	CbGeAlD
Doxorubicin—CBR1—cardiovascular system—type 2 diabetes mellitus	0.000243	0.00383	CbGeAlD
Doxorubicin—CBR1—kidney—type 2 diabetes mellitus	0.000238	0.00375	CbGeAlD
Doxorubicin—AKR1C3—pancreas—type 2 diabetes mellitus	0.000234	0.00367	CbGeAlD
Doxorubicin—AURKA—liver—type 2 diabetes mellitus	0.000233	0.00366	CbGeAlD
Doxorubicin—CBR1—cortex of kidney—type 2 diabetes mellitus	0.000232	0.00365	CbGeAlD
Doxorubicin—NQO1—retina—type 2 diabetes mellitus	0.00023	0.00363	CbGeAlD
Doxorubicin—RALBP1—adipose tissue—type 2 diabetes mellitus	0.00023	0.00362	CbGeAlD
Doxorubicin—AKR1C3—cortex of kidney—type 2 diabetes mellitus	0.000229	0.0036	CbGeAlD
Doxorubicin—NQO1—nephron tubule—type 2 diabetes mellitus	0.000217	0.00341	CbGeAlD
Doxorubicin—CBR1—adipose tissue—type 2 diabetes mellitus	0.000215	0.00338	CbGeAlD
Doxorubicin—AKR1C3—adipose tissue—type 2 diabetes mellitus	0.000212	0.00333	CbGeAlD
Doxorubicin—POR—cortex of kidney—type 2 diabetes mellitus	0.000209	0.00329	CbGeAlD
Doxorubicin—NDUFS2—liver—type 2 diabetes mellitus	0.000207	0.00326	CbGeAlD
Doxorubicin—NDUFS3—liver—type 2 diabetes mellitus	0.000205	0.00322	CbGeAlD
Doxorubicin—NQO1—cardiovascular system—type 2 diabetes mellitus	0.000195	0.00307	CbGeAlD
Doxorubicin—DHCR7—liver—type 2 diabetes mellitus	0.000194	0.00306	CbGeAlD
Doxorubicin—POR—adipose tissue—type 2 diabetes mellitus	0.000193	0.00304	CbGeAlD
Doxorubicin—NQO1—kidney—type 2 diabetes mellitus	0.000191	0.003	CbGeAlD
Doxorubicin—ABCC6—liver—type 2 diabetes mellitus	0.00019	0.00298	CbGeAlD
Doxorubicin—NQO1—pancreas—type 2 diabetes mellitus	0.000189	0.00298	CbGeAlD
Doxorubicin—NQO1—cortex of kidney—type 2 diabetes mellitus	0.000186	0.00292	CbGeAlD
Doxorubicin—TOP2A—adipose tissue—type 2 diabetes mellitus	0.00018	0.00284	CbGeAlD
Doxorubicin—YWHAG—liver—type 2 diabetes mellitus	0.000178	0.00281	CbGeAlD
Doxorubicin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000177	0.16	CbGdCrCtD
Doxorubicin—XDH—liver—type 2 diabetes mellitus	0.000174	0.00274	CbGeAlD
Doxorubicin—NQO1—adipose tissue—type 2 diabetes mellitus	0.000172	0.0027	CbGeAlD
Doxorubicin—ABCC3—kidney—type 2 diabetes mellitus	0.000171	0.00269	CbGeAlD
Doxorubicin—ABCC10—kidney—type 2 diabetes mellitus	0.00017	0.00268	CbGeAlD
Doxorubicin—ABCB11—liver—type 2 diabetes mellitus	0.00017	0.00267	CbGeAlD
Doxorubicin—ABCC10—cortex of kidney—type 2 diabetes mellitus	0.000166	0.00261	CbGeAlD
Doxorubicin—Daunorubicin—CYP3A4—type 2 diabetes mellitus	0.000163	0.209	CrCbGaD
Doxorubicin—RALBP1—liver—type 2 diabetes mellitus	0.000161	0.00254	CbGeAlD
Doxorubicin—NOS3—liver—type 2 diabetes mellitus	0.000159	0.00249	CbGeAlD
Doxorubicin—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000156	0.00245	CbGeAlD
Doxorubicin—ABCC3—adipose tissue—type 2 diabetes mellitus	0.000154	0.00243	CbGeAlD
Doxorubicin—ABCC10—adipose tissue—type 2 diabetes mellitus	0.000154	0.00242	CbGeAlD
Doxorubicin—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000152	0.0024	CbGeAlD
Doxorubicin—CBR1—liver—type 2 diabetes mellitus	0.00015	0.00237	CbGeAlD
Doxorubicin—AKR1C3—liver—type 2 diabetes mellitus	0.000149	0.00234	CbGeAlD
Doxorubicin—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000137	0.00215	CbGeAlD
Doxorubicin—ABCC2—kidney—type 2 diabetes mellitus	0.000137	0.00215	CbGeAlD
Doxorubicin—POR—liver—type 2 diabetes mellitus	0.000136	0.00213	CbGeAlD
Doxorubicin—CYP1B1—kidney—type 2 diabetes mellitus	0.000134	0.00211	CbGeAlD
Doxorubicin—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000133	0.0021	CbGeAlD
Doxorubicin—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.00013	0.00205	CbGeAlD
Doxorubicin—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000121	0.0019	CbGeAlD
Doxorubicin—NQO1—liver—type 2 diabetes mellitus	0.000121	0.0019	CbGeAlD
Doxorubicin—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000117	0.00185	CbGeAlD
Doxorubicin—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000113	0.00179	CbGeAlD
Doxorubicin—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000109	0.00171	CbGeAlD
Doxorubicin—ABCC3—liver—type 2 diabetes mellitus	0.000108	0.0017	CbGeAlD
Doxorubicin—ABCC10—liver—type 2 diabetes mellitus	0.000108	0.00169	CbGeAlD
Doxorubicin—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000105	0.00165	CbGeAlD
Doxorubicin—CYP2B6—cardiovascular system—type 2 diabetes mellitus	9.4e-05	0.00148	CbGeAlD
Doxorubicin—CYP2B6—kidney—type 2 diabetes mellitus	9.2e-05	0.00145	CbGeAlD
Doxorubicin—ABCG2—adipose tissue—type 2 diabetes mellitus	8.99e-05	0.00141	CbGeAlD
Doxorubicin—ABCC2—liver—type 2 diabetes mellitus	8.64e-05	0.00136	CbGeAlD
Doxorubicin—CYP1B1—liver—type 2 diabetes mellitus	8.47e-05	0.00133	CbGeAlD
Doxorubicin—ABCC1—liver—type 2 diabetes mellitus	7.61e-05	0.0012	CbGeAlD
Doxorubicin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	6.95e-05	0.00109	CbGeAlD
Doxorubicin—CYP3A4—kidney—type 2 diabetes mellitus	6.95e-05	0.00109	CbGeAlD
Doxorubicin—CYP2D6—kidney—type 2 diabetes mellitus	6.84e-05	0.00108	CbGeAlD
Doxorubicin—ABCG2—liver—type 2 diabetes mellitus	6.3e-05	0.000992	CbGeAlD
Doxorubicin—ABCB1—retina—type 2 diabetes mellitus	5.94e-05	0.000935	CbGeAlD
Doxorubicin—CYP2B6—liver—type 2 diabetes mellitus	5.82e-05	0.000915	CbGeAlD
Doxorubicin—ABCB1—nephron tubule—type 2 diabetes mellitus	5.6e-05	0.00088	CbGeAlD
Doxorubicin—ABCB1—cardiovascular system—type 2 diabetes mellitus	5.03e-05	0.000791	CbGeAlD
Doxorubicin—ABCB1—kidney—type 2 diabetes mellitus	4.92e-05	0.000774	CbGeAlD
Doxorubicin—ABCB1—pancreas—type 2 diabetes mellitus	4.89e-05	0.000769	CbGeAlD
Doxorubicin—ABCB1—cortex of kidney—type 2 diabetes mellitus	4.79e-05	0.000754	CbGeAlD
Doxorubicin—ABCB1—adipose tissue—type 2 diabetes mellitus	4.43e-05	0.000697	CbGeAlD
Doxorubicin—CYP3A4—liver—type 2 diabetes mellitus	4.39e-05	0.000691	CbGeAlD
Doxorubicin—CYP2D6—liver—type 2 diabetes mellitus	4.32e-05	0.00068	CbGeAlD
Doxorubicin—Nervous system disorder—Metformin—type 2 diabetes mellitus	3.32e-05	0.000278	CcSEcCtD
Doxorubicin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.31e-05	0.000277	CcSEcCtD
Doxorubicin—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000277	CcSEcCtD
Doxorubicin—Vertigo—Losartan—type 2 diabetes mellitus	3.31e-05	0.000277	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.31e-05	0.000277	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.31e-05	0.000277	CcSEcCtD
Doxorubicin—Somnolence—Valsartan—type 2 diabetes mellitus	3.3e-05	0.000277	CcSEcCtD
Doxorubicin—Syncope—Losartan—type 2 diabetes mellitus	3.3e-05	0.000277	CcSEcCtD
Doxorubicin—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.3e-05	0.000276	CcSEcCtD
Doxorubicin—Leukopenia—Losartan—type 2 diabetes mellitus	3.3e-05	0.000276	CcSEcCtD
Doxorubicin—Discomfort—Irbesartan—type 2 diabetes mellitus	3.29e-05	0.000276	CcSEcCtD
Doxorubicin—Skin disorder—Metformin—type 2 diabetes mellitus	3.29e-05	0.000275	CcSEcCtD
Doxorubicin—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000274	CcSEcCtD
Doxorubicin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.27e-05	0.000274	CcSEcCtD
Doxorubicin—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.27e-05	0.000274	CcSEcCtD
Doxorubicin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000274	CcSEcCtD
Doxorubicin—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.26e-05	0.000273	CcSEcCtD
Doxorubicin—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.26e-05	0.000273	CcSEcCtD
Doxorubicin—Palpitations—Losartan—type 2 diabetes mellitus	3.26e-05	0.000272	CcSEcCtD
Doxorubicin—Nausea—Glimepiride—type 2 diabetes mellitus	3.25e-05	0.000272	CcSEcCtD
Doxorubicin—Arrhythmia—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000271	CcSEcCtD
Doxorubicin—Loss of consciousness—Losartan—type 2 diabetes mellitus	3.24e-05	0.000271	CcSEcCtD
Doxorubicin—Nausea—Sitagliptin—type 2 diabetes mellitus	3.24e-05	0.000271	CcSEcCtD
Doxorubicin—Dyspepsia—Orlistat—type 2 diabetes mellitus	3.23e-05	0.000271	CcSEcCtD
Doxorubicin—Asthenia—Glyburide—type 2 diabetes mellitus	3.23e-05	0.000271	CcSEcCtD
Doxorubicin—Decreased appetite—Valsartan—type 2 diabetes mellitus	3.23e-05	0.00027	CcSEcCtD
Doxorubicin—Anorexia—Metformin—type 2 diabetes mellitus	3.23e-05	0.00027	CcSEcCtD
Doxorubicin—Cough—Losartan—type 2 diabetes mellitus	3.21e-05	0.000269	CcSEcCtD
Doxorubicin—Urticaria—Gliclazide—type 2 diabetes mellitus	3.21e-05	0.000269	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	3.21e-05	0.000269	CcSEcCtD
Doxorubicin—Alopecia—Ramipril—type 2 diabetes mellitus	3.21e-05	0.000268	CcSEcCtD
Doxorubicin—Fatigue—Valsartan—type 2 diabetes mellitus	3.2e-05	0.000268	CcSEcCtD
Doxorubicin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000268	CcSEcCtD
Doxorubicin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	3.2e-05	0.000268	CcSEcCtD
Doxorubicin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000267	CcSEcCtD
Doxorubicin—Oedema—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000267	CcSEcCtD
Doxorubicin—Decreased appetite—Orlistat—type 2 diabetes mellitus	3.19e-05	0.000267	CcSEcCtD
Doxorubicin—Pruritus—Glyburide—type 2 diabetes mellitus	3.19e-05	0.000267	CcSEcCtD
Doxorubicin—Mental disorder—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000266	CcSEcCtD
Doxorubicin—Constipation—Valsartan—type 2 diabetes mellitus	3.18e-05	0.000266	CcSEcCtD
Doxorubicin—Infection—Irbesartan—type 2 diabetes mellitus	3.17e-05	0.000266	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	3.17e-05	0.000265	CcSEcCtD
Doxorubicin—Fatigue—Orlistat—type 2 diabetes mellitus	3.17e-05	0.000265	CcSEcCtD
Doxorubicin—Hypotension—Metformin—type 2 diabetes mellitus	3.16e-05	0.000265	CcSEcCtD
Doxorubicin—Erythema—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000264	CcSEcCtD
Doxorubicin—Malnutrition—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000264	CcSEcCtD
Doxorubicin—Shock—Irbesartan—type 2 diabetes mellitus	3.14e-05	0.000263	CcSEcCtD
Doxorubicin—Pain—Orlistat—type 2 diabetes mellitus	3.14e-05	0.000263	CcSEcCtD
Doxorubicin—Chest pain—Losartan—type 2 diabetes mellitus	3.14e-05	0.000263	CcSEcCtD
Doxorubicin—Arthralgia—Losartan—type 2 diabetes mellitus	3.14e-05	0.000263	CcSEcCtD
Doxorubicin—Myalgia—Losartan—type 2 diabetes mellitus	3.14e-05	0.000263	CcSEcCtD
Doxorubicin—Vomiting—Bromocriptine—type 2 diabetes mellitus	3.13e-05	0.000262	CcSEcCtD
Doxorubicin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.000262	CcSEcCtD
Doxorubicin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	3.13e-05	0.000262	CcSEcCtD
Doxorubicin—Anxiety—Losartan—type 2 diabetes mellitus	3.13e-05	0.000262	CcSEcCtD
Doxorubicin—Tachycardia—Irbesartan—type 2 diabetes mellitus	3.12e-05	0.000261	CcSEcCtD
Doxorubicin—ABCB1—liver—type 2 diabetes mellitus	3.11e-05	0.000489	CbGeAlD
Doxorubicin—Rash—Bromocriptine—type 2 diabetes mellitus	3.11e-05	0.00026	CcSEcCtD
Doxorubicin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	3.1e-05	0.00026	CcSEcCtD
Doxorubicin—Skin disorder—Irbesartan—type 2 diabetes mellitus	3.1e-05	0.00026	CcSEcCtD
Doxorubicin—Tension—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000259	CcSEcCtD
Doxorubicin—Discomfort—Losartan—type 2 diabetes mellitus	3.1e-05	0.000259	CcSEcCtD
Doxorubicin—Dysgeusia—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000259	CcSEcCtD
Doxorubicin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	3.09e-05	0.000259	CcSEcCtD
Doxorubicin—Headache—Bromocriptine—type 2 diabetes mellitus	3.09e-05	0.000258	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	3.08e-05	0.000258	CcSEcCtD
Doxorubicin—Diarrhoea—Glyburide—type 2 diabetes mellitus	3.08e-05	0.000258	CcSEcCtD
Doxorubicin—Nervousness—Ramipril—type 2 diabetes mellitus	3.07e-05	0.000257	CcSEcCtD
Doxorubicin—Dry mouth—Losartan—type 2 diabetes mellitus	3.07e-05	0.000257	CcSEcCtD
Doxorubicin—Anorexia—Irbesartan—type 2 diabetes mellitus	3.05e-05	0.000255	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	3.04e-05	0.000254	CcSEcCtD
Doxorubicin—Paraesthesia—Metformin—type 2 diabetes mellitus	3.04e-05	0.000254	CcSEcCtD
Doxorubicin—Muscle spasms—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000254	CcSEcCtD
Doxorubicin—Confusional state—Losartan—type 2 diabetes mellitus	3.03e-05	0.000254	CcSEcCtD
Doxorubicin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	3.03e-05	0.000253	CcSEcCtD
Doxorubicin—Dyspnoea—Metformin—type 2 diabetes mellitus	3.02e-05	0.000253	CcSEcCtD
Doxorubicin—Somnolence—Metformin—type 2 diabetes mellitus	3.01e-05	0.000252	CcSEcCtD
Doxorubicin—Oedema—Losartan—type 2 diabetes mellitus	3.01e-05	0.000252	CcSEcCtD
Doxorubicin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.01e-05	0.000252	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3e-05	0.000251	CcSEcCtD
Doxorubicin—Infection—Losartan—type 2 diabetes mellitus	2.99e-05	0.00025	CcSEcCtD
Doxorubicin—Hypotension—Irbesartan—type 2 diabetes mellitus	2.99e-05	0.00025	CcSEcCtD
Doxorubicin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	2.98e-05	0.00025	CcSEcCtD
Doxorubicin—Dyspepsia—Metformin—type 2 diabetes mellitus	2.98e-05	0.000249	CcSEcCtD
Doxorubicin—Shock—Losartan—type 2 diabetes mellitus	2.96e-05	0.000248	CcSEcCtD
Doxorubicin—Urticaria—Valsartan—type 2 diabetes mellitus	2.95e-05	0.000247	CcSEcCtD
Doxorubicin—Nervous system disorder—Losartan—type 2 diabetes mellitus	2.95e-05	0.000247	CcSEcCtD
Doxorubicin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.94e-05	0.000246	CcSEcCtD
Doxorubicin—Decreased appetite—Metformin—type 2 diabetes mellitus	2.94e-05	0.000246	CcSEcCtD
Doxorubicin—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.94e-05	0.000246	CcSEcCtD
Doxorubicin—Tachycardia—Losartan—type 2 diabetes mellitus	2.93e-05	0.000246	CcSEcCtD
Doxorubicin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000245	CcSEcCtD
Doxorubicin—Nausea—Bromocriptine—type 2 diabetes mellitus	2.93e-05	0.000245	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.92e-05	0.000245	CcSEcCtD
Doxorubicin—Fatigue—Metformin—type 2 diabetes mellitus	2.92e-05	0.000244	CcSEcCtD
Doxorubicin—Urticaria—Orlistat—type 2 diabetes mellitus	2.92e-05	0.000244	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.91e-05	0.000244	CcSEcCtD
Doxorubicin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.91e-05	0.000243	CcSEcCtD
Doxorubicin—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000243	CcSEcCtD
Doxorubicin—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000243	CcSEcCtD
Doxorubicin—Asthenia—Gliclazide—type 2 diabetes mellitus	2.9e-05	0.000243	CcSEcCtD
Doxorubicin—Agitation—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000243	CcSEcCtD
Doxorubicin—Constipation—Metformin—type 2 diabetes mellitus	2.89e-05	0.000242	CcSEcCtD
Doxorubicin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.00024	CcSEcCtD
Doxorubicin—Anorexia—Losartan—type 2 diabetes mellitus	2.87e-05	0.00024	CcSEcCtD
Doxorubicin—Vomiting—Glyburide—type 2 diabetes mellitus	2.86e-05	0.00024	CcSEcCtD
Doxorubicin—Pruritus—Gliclazide—type 2 diabetes mellitus	2.86e-05	0.00024	CcSEcCtD
Doxorubicin—Malaise—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000238	CcSEcCtD
Doxorubicin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.85e-05	0.000238	CcSEcCtD
Doxorubicin—Rash—Glyburide—type 2 diabetes mellitus	2.84e-05	0.000238	CcSEcCtD
Doxorubicin—Somnolence—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000238	CcSEcCtD
Doxorubicin—Dermatitis—Glyburide—type 2 diabetes mellitus	2.84e-05	0.000238	CcSEcCtD
Doxorubicin—Vertigo—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000238	CcSEcCtD
Doxorubicin—Syncope—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000237	CcSEcCtD
Doxorubicin—Leukopenia—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000237	CcSEcCtD
Doxorubicin—Headache—Glyburide—type 2 diabetes mellitus	2.82e-05	0.000236	CcSEcCtD
Doxorubicin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.81e-05	0.000235	CcSEcCtD
Doxorubicin—Hypotension—Losartan—type 2 diabetes mellitus	2.81e-05	0.000235	CcSEcCtD
Doxorubicin—Palpitations—Ramipril—type 2 diabetes mellitus	2.79e-05	0.000234	CcSEcCtD
Doxorubicin—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.79e-05	0.000233	CcSEcCtD
Doxorubicin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.78e-05	0.000232	CcSEcCtD
Doxorubicin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000232	CcSEcCtD
Doxorubicin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.77e-05	0.000232	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.77e-05	0.000232	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000231	CcSEcCtD
Doxorubicin—Cough—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000231	CcSEcCtD
Doxorubicin—Fatigue—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000231	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.74e-05	0.000229	CcSEcCtD
Doxorubicin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.74e-05	0.000229	CcSEcCtD
Doxorubicin—Convulsion—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000229	CcSEcCtD
Doxorubicin—Pain—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000229	CcSEcCtD
Doxorubicin—Constipation—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000229	CcSEcCtD
Doxorubicin—Insomnia—Losartan—type 2 diabetes mellitus	2.72e-05	0.000228	CcSEcCtD
Doxorubicin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.71e-05	0.000227	CcSEcCtD
Doxorubicin—Paraesthesia—Losartan—type 2 diabetes mellitus	2.7e-05	0.000226	CcSEcCtD
Doxorubicin—Urticaria—Metformin—type 2 diabetes mellitus	2.69e-05	0.000225	CcSEcCtD
Doxorubicin—Myalgia—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000225	CcSEcCtD
Doxorubicin—Arthralgia—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000225	CcSEcCtD
Doxorubicin—Chest pain—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000225	CcSEcCtD
Doxorubicin—Dyspnoea—Losartan—type 2 diabetes mellitus	2.68e-05	0.000224	CcSEcCtD
Doxorubicin—Anxiety—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000224	CcSEcCtD
Doxorubicin—Nausea—Glyburide—type 2 diabetes mellitus	2.68e-05	0.000224	CcSEcCtD
Doxorubicin—Abdominal pain—Metformin—type 2 diabetes mellitus	2.68e-05	0.000224	CcSEcCtD
Doxorubicin—Dizziness—Gliclazide—type 2 diabetes mellitus	2.68e-05	0.000224	CcSEcCtD
Doxorubicin—Somnolence—Losartan—type 2 diabetes mellitus	2.67e-05	0.000224	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.67e-05	0.000224	CcSEcCtD
Doxorubicin—Asthenia—Valsartan—type 2 diabetes mellitus	2.67e-05	0.000223	CcSEcCtD
Doxorubicin—Discomfort—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000222	CcSEcCtD
Doxorubicin—Dyspepsia—Losartan—type 2 diabetes mellitus	2.65e-05	0.000222	CcSEcCtD
Doxorubicin—Asthenia—Orlistat—type 2 diabetes mellitus	2.64e-05	0.000221	CcSEcCtD
Doxorubicin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.63e-05	0.00022	CcSEcCtD
Doxorubicin—Pruritus—Valsartan—type 2 diabetes mellitus	2.63e-05	0.00022	CcSEcCtD
Doxorubicin—Dry mouth—Ramipril—type 2 diabetes mellitus	2.63e-05	0.00022	CcSEcCtD
Doxorubicin—Decreased appetite—Losartan—type 2 diabetes mellitus	2.61e-05	0.000219	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.61e-05	0.000219	CcSEcCtD
Doxorubicin—Confusional state—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000218	CcSEcCtD
Doxorubicin—Pruritus—Orlistat—type 2 diabetes mellitus	2.6e-05	0.000218	CcSEcCtD
Doxorubicin—Fatigue—Losartan—type 2 diabetes mellitus	2.59e-05	0.000217	CcSEcCtD
Doxorubicin—Oedema—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000216	CcSEcCtD
Doxorubicin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000216	CcSEcCtD
Doxorubicin—Vomiting—Gliclazide—type 2 diabetes mellitus	2.57e-05	0.000215	CcSEcCtD
Doxorubicin—Pain—Losartan—type 2 diabetes mellitus	2.57e-05	0.000215	CcSEcCtD
Doxorubicin—Constipation—Losartan—type 2 diabetes mellitus	2.57e-05	0.000215	CcSEcCtD
Doxorubicin—Rash—Gliclazide—type 2 diabetes mellitus	2.55e-05	0.000214	CcSEcCtD
Doxorubicin—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.55e-05	0.000213	CcSEcCtD
Doxorubicin—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.54e-05	0.000213	CcSEcCtD
Doxorubicin—Urticaria—Irbesartan—type 2 diabetes mellitus	2.54e-05	0.000212	CcSEcCtD
Doxorubicin—Shock—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000212	CcSEcCtD
Doxorubicin—Headache—Gliclazide—type 2 diabetes mellitus	2.53e-05	0.000212	CcSEcCtD
Doxorubicin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.53e-05	0.000212	CcSEcCtD
Doxorubicin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.53e-05	0.000211	CcSEcCtD
Doxorubicin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.53e-05	0.000211	CcSEcCtD
Doxorubicin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000211	CcSEcCtD
Doxorubicin—Tachycardia—Ramipril—type 2 diabetes mellitus	2.52e-05	0.000211	CcSEcCtD
Doxorubicin—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.51e-05	0.00021	CcSEcCtD
Doxorubicin—Skin disorder—Ramipril—type 2 diabetes mellitus	2.5e-05	0.00021	CcSEcCtD
Doxorubicin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000209	CcSEcCtD
Doxorubicin—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.48e-05	0.000207	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.46e-05	0.000206	CcSEcCtD
Doxorubicin—Dizziness—Valsartan—type 2 diabetes mellitus	2.46e-05	0.000206	CcSEcCtD
Doxorubicin—Anorexia—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000206	CcSEcCtD
Doxorubicin—Dizziness—Orlistat—type 2 diabetes mellitus	2.43e-05	0.000203	CcSEcCtD
Doxorubicin—Asthenia—Metformin—type 2 diabetes mellitus	2.43e-05	0.000203	CcSEcCtD
Doxorubicin—Hypotension—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000202	CcSEcCtD
Doxorubicin—Nausea—Gliclazide—type 2 diabetes mellitus	2.4e-05	0.000201	CcSEcCtD
Doxorubicin—Pruritus—Metformin—type 2 diabetes mellitus	2.39e-05	0.0002	CcSEcCtD
Doxorubicin—Urticaria—Losartan—type 2 diabetes mellitus	2.39e-05	0.0002	CcSEcCtD
Doxorubicin—Body temperature increased—Losartan—type 2 diabetes mellitus	2.38e-05	0.000199	CcSEcCtD
Doxorubicin—Abdominal pain—Losartan—type 2 diabetes mellitus	2.38e-05	0.000199	CcSEcCtD
Doxorubicin—Vomiting—Valsartan—type 2 diabetes mellitus	2.36e-05	0.000198	CcSEcCtD
Doxorubicin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.35e-05	0.000197	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.35e-05	0.000197	CcSEcCtD
Doxorubicin—Rash—Valsartan—type 2 diabetes mellitus	2.34e-05	0.000196	CcSEcCtD
Doxorubicin—Dermatitis—Valsartan—type 2 diabetes mellitus	2.34e-05	0.000196	CcSEcCtD
Doxorubicin—Vomiting—Orlistat—type 2 diabetes mellitus	2.34e-05	0.000195	CcSEcCtD
Doxorubicin—Insomnia—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000195	CcSEcCtD
Doxorubicin—Headache—Valsartan—type 2 diabetes mellitus	2.33e-05	0.000195	CcSEcCtD
Doxorubicin—Diarrhoea—Metformin—type 2 diabetes mellitus	2.32e-05	0.000194	CcSEcCtD
Doxorubicin—Rash—Orlistat—type 2 diabetes mellitus	2.32e-05	0.000194	CcSEcCtD
Doxorubicin—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000194	CcSEcCtD
Doxorubicin—Dermatitis—Orlistat—type 2 diabetes mellitus	2.31e-05	0.000194	CcSEcCtD
Doxorubicin—Headache—Orlistat—type 2 diabetes mellitus	2.3e-05	0.000193	CcSEcCtD
Doxorubicin—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000192	CcSEcCtD
Doxorubicin—Asthenia—Irbesartan—type 2 diabetes mellitus	2.29e-05	0.000192	CcSEcCtD
Doxorubicin—Somnolence—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000192	CcSEcCtD
Doxorubicin—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.27e-05	0.00019	CcSEcCtD
Doxorubicin—Pruritus—Irbesartan—type 2 diabetes mellitus	2.26e-05	0.000189	CcSEcCtD
Doxorubicin—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.24e-05	0.000188	CcSEcCtD
Doxorubicin—Dizziness—Metformin—type 2 diabetes mellitus	2.24e-05	0.000187	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.23e-05	0.000186	CcSEcCtD
Doxorubicin—Fatigue—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000186	CcSEcCtD
Doxorubicin—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.21e-05	0.000185	CcSEcCtD
Doxorubicin—Nausea—Valsartan—type 2 diabetes mellitus	2.21e-05	0.000185	CcSEcCtD
Doxorubicin—Constipation—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000185	CcSEcCtD
Doxorubicin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.19e-05	0.000183	CcSEcCtD
Doxorubicin—Nausea—Orlistat—type 2 diabetes mellitus	2.18e-05	0.000183	CcSEcCtD
Doxorubicin—Asthenia—Losartan—type 2 diabetes mellitus	2.16e-05	0.000181	CcSEcCtD
Doxorubicin—Vomiting—Metformin—type 2 diabetes mellitus	2.15e-05	0.00018	CcSEcCtD
Doxorubicin—Rash—Metformin—type 2 diabetes mellitus	2.13e-05	0.000179	CcSEcCtD
Doxorubicin—Dermatitis—Metformin—type 2 diabetes mellitus	2.13e-05	0.000178	CcSEcCtD
Doxorubicin—Pruritus—Losartan—type 2 diabetes mellitus	2.13e-05	0.000178	CcSEcCtD
Doxorubicin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000178	CcSEcCtD
Doxorubicin—Headache—Metformin—type 2 diabetes mellitus	2.12e-05	0.000178	CcSEcCtD
Doxorubicin—Dizziness—Irbesartan—type 2 diabetes mellitus	2.11e-05	0.000177	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000176	CcSEcCtD
Doxorubicin—Diarrhoea—Losartan—type 2 diabetes mellitus	2.06e-05	0.000172	CcSEcCtD
Doxorubicin—Urticaria—Ramipril—type 2 diabetes mellitus	2.05e-05	0.000171	CcSEcCtD
Doxorubicin—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000171	CcSEcCtD
Doxorubicin—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.04e-05	0.000171	CcSEcCtD
Doxorubicin—Vomiting—Irbesartan—type 2 diabetes mellitus	2.03e-05	0.00017	CcSEcCtD
Doxorubicin—Rash—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000169	CcSEcCtD
Doxorubicin—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.01e-05	0.000168	CcSEcCtD
Doxorubicin—Nausea—Metformin—type 2 diabetes mellitus	2.01e-05	0.000168	CcSEcCtD
Doxorubicin—Headache—Irbesartan—type 2 diabetes mellitus	2e-05	0.000168	CcSEcCtD
Doxorubicin—Dizziness—Losartan—type 2 diabetes mellitus	1.99e-05	0.000166	CcSEcCtD
Doxorubicin—Vomiting—Losartan—type 2 diabetes mellitus	1.91e-05	0.00016	CcSEcCtD
Doxorubicin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.9e-05	0.000159	CcSEcCtD
Doxorubicin—Nausea—Irbesartan—type 2 diabetes mellitus	1.9e-05	0.000159	CcSEcCtD
Doxorubicin—Rash—Losartan—type 2 diabetes mellitus	1.9e-05	0.000159	CcSEcCtD
Doxorubicin—Dermatitis—Losartan—type 2 diabetes mellitus	1.89e-05	0.000159	CcSEcCtD
Doxorubicin—Headache—Losartan—type 2 diabetes mellitus	1.88e-05	0.000158	CcSEcCtD
Doxorubicin—Asthenia—Ramipril—type 2 diabetes mellitus	1.85e-05	0.000155	CcSEcCtD
Doxorubicin—Pruritus—Ramipril—type 2 diabetes mellitus	1.82e-05	0.000153	CcSEcCtD
Doxorubicin—Nausea—Losartan—type 2 diabetes mellitus	1.79e-05	0.000149	CcSEcCtD
Doxorubicin—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.76e-05	0.000148	CcSEcCtD
Doxorubicin—Dizziness—Ramipril—type 2 diabetes mellitus	1.7e-05	0.000143	CcSEcCtD
Doxorubicin—Vomiting—Ramipril—type 2 diabetes mellitus	1.64e-05	0.000137	CcSEcCtD
Doxorubicin—Rash—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000136	CcSEcCtD
Doxorubicin—Dermatitis—Ramipril—type 2 diabetes mellitus	1.62e-05	0.000136	CcSEcCtD
Doxorubicin—Headache—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000135	CcSEcCtD
Doxorubicin—Nausea—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000128	CcSEcCtD
Doxorubicin—CYP1B1—Metabolism—APOA1—type 2 diabetes mellitus	1.37e-06	1.39e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NOS3—type 2 diabetes mellitus	1.37e-06	1.39e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.37e-06	1.39e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	1.37e-06	1.39e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	1.37e-06	1.39e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—type 2 diabetes mellitus	1.37e-06	1.38e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.37e-06	1.38e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.37e-06	1.38e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.37e-06	1.38e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	1.36e-06	1.37e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—type 2 diabetes mellitus	1.35e-06	1.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	1.35e-06	1.36e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	1.34e-06	1.36e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	1.34e-06	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	1.34e-06	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	1.34e-06	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	1.33e-06	1.35e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.33e-06	1.34e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.32e-06	1.34e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.3e-06	1.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.29e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.29e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.29e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	1.29e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	1.29e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—type 2 diabetes mellitus	1.29e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	1.29e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	1.27e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.27e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.27e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	1.26e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.26e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.26e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.26e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.26e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.26e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.26e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	1.25e-06	1.27e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—type 2 diabetes mellitus	1.25e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.23e-06	1.24e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—INS—type 2 diabetes mellitus	1.23e-06	1.24e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.22e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.22e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.22e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	1.21e-06	1.22e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.2e-06	1.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.2e-06	1.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.2e-06	1.21e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	1.19e-06	1.21e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—INS—type 2 diabetes mellitus	1.19e-06	1.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-06	1.2e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.18e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	1.18e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.17e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.17e-06	1.18e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	1.16e-06	1.17e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	1.17e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—type 2 diabetes mellitus	1.15e-06	1.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.15e-06	1.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.14e-06	1.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.14e-06	1.16e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.13e-06	1.15e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.13e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.13e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.13e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	1.13e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	1.13e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.11e-06	1.12e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	1.11e-06	1.12e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	1.1e-06	1.11e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.1e-06	1.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.1e-06	1.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.09e-06	1.11e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ALB—type 2 diabetes mellitus	1.09e-06	1.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.08e-06	1.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.08e-06	1.1e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	1.08e-06	1.1e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—INS—type 2 diabetes mellitus	1.08e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	1.08e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.08e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	1.08e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.08e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.07e-06	1.09e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-06	1.08e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.06e-06	1.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—type 2 diabetes mellitus	1.05e-06	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	1.05e-06	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.04e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.03e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.02e-06	1.03e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.02e-06	1.03e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	9.96e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—type 2 diabetes mellitus	9.96e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	9.95e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9.93e-07	1.01e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	9.9e-07	1e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	9.84e-07	9.97e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	9.79e-07	9.91e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	9.79e-07	9.91e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.77e-07	9.89e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	9.76e-07	9.89e-06	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—type 2 diabetes mellitus	9.69e-07	9.82e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—type 2 diabetes mellitus	9.61e-07	9.73e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.58e-07	9.69e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—type 2 diabetes mellitus	9.52e-07	9.64e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SRC—type 2 diabetes mellitus	9.51e-07	9.62e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.47e-07	9.59e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	9.47e-07	9.59e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	9.46e-07	9.57e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	9.3e-07	9.41e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	9.27e-07	9.38e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	9.24e-07	9.35e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	9.16e-07	9.27e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	8.96e-07	9.07e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.96e-07	9.07e-06	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—type 2 diabetes mellitus	8.93e-07	9.04e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	8.91e-07	9.03e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	8.8e-07	8.91e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—type 2 diabetes mellitus	8.71e-07	8.82e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	8.66e-07	8.77e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	8.62e-07	8.73e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	8.54e-07	8.65e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	8.5e-07	8.6e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	8.45e-07	8.55e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	8.45e-07	8.55e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	8.44e-07	8.54e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.44e-07	8.54e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	8.4e-07	8.51e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—type 2 diabetes mellitus	8.33e-07	8.44e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	8.31e-07	8.41e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	8.29e-07	8.39e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	8.28e-07	8.39e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	8.23e-07	8.33e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	8.23e-07	8.33e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	8.23e-07	8.33e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	8.18e-07	8.28e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	8.15e-07	8.25e-06	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—type 2 diabetes mellitus	8.12e-07	8.22e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	8.07e-07	8.17e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	8.05e-07	8.15e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	8.03e-07	8.13e-06	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.03e-07	8.13e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	7.98e-07	8.08e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	7.95e-07	8.05e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.94e-07	8.04e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	7.92e-07	8.01e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	7.83e-07	7.93e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	7.75e-07	7.84e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	7.68e-07	7.78e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.65e-07	7.75e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	7.52e-07	7.62e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	7.5e-07	7.59e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.38e-07	7.48e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.38e-07	7.48e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.38e-07	7.48e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.36e-07	7.45e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	7.34e-07	7.43e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	7.3e-07	7.39e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	7.26e-07	7.35e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.25e-07	7.34e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.21e-07	7.3e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	7.2e-07	7.29e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.18e-07	7.27e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.03e-07	7.12e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	6.98e-07	7.06e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	6.94e-07	7.03e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	6.94e-07	7.03e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	6.92e-07	7e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	6.86e-07	6.94e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	6.83e-07	6.92e-06	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.79e-07	6.87e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	6.79e-07	6.87e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	6.76e-07	6.84e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.75e-07	6.84e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.68e-07	6.76e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.68e-07	6.76e-06	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—type 2 diabetes mellitus	6.59e-07	6.67e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	6.57e-07	6.65e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.46e-07	6.54e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	6.44e-07	6.52e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—type 2 diabetes mellitus	6.4e-07	6.48e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.4e-07	6.48e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.4e-07	6.48e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.37e-07	6.45e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	6.35e-07	6.43e-06	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	6.31e-07	6.39e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	5.95e-07	6.03e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—type 2 diabetes mellitus	5.91e-07	5.98e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5.84e-07	5.91e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.61e-07	5.68e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.52e-07	5.59e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.52e-07	5.59e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.5e-07	5.57e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.49e-07	5.56e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.42e-07	5.49e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	5.35e-07	5.42e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.26e-07	5.33e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.12e-07	5.18e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.12e-07	5.18e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.12e-07	5.18e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.04e-07	5.11e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.02e-07	5.09e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	4.95e-07	5.01e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.92e-07	4.98e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.9e-07	4.96e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.82e-07	4.88e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.82e-07	4.88e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	4.79e-07	4.84e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.77e-07	4.83e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.71e-07	4.77e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.68e-07	4.74e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.52e-07	4.58e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.44e-07	4.49e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.41e-07	4.47e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	4.35e-07	4.41e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.3e-07	4.35e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.23e-07	4.28e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.21e-07	4.26e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.16e-07	4.21e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.67e-07	3.71e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.6e-07	3.64e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.3e-07	3.34e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	3.19e-07	3.23e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.15e-07	3.19e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.15e-07	3.19e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.89e-07	2.92e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.35e-07	2.38e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.22e-07	2.25e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.45e-07	1.47e-06	CbGpPWpGaD
